Aquestive Therapeutics Inc. (AQST) Tops Q3 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts AQST Hot Sheet
Join SI Premium – FREE
Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q3 EPS of ($0.03), $0.08 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $13 million versus the consensus estimate of $11.51 million.
For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BlackSky (BKSY) Tops Q3 EPS by 32c ; Offers Guidance
- Advanced Drainage Systems (WMS) Tops Q2 EPS by 7c; offers guidance
- Xeris Pharmaceuticals Inc. (XERS) Tops Q3 EPS by 3c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
